Loading insider details...
Latest Form 4 (Nov 3, 2026): Purchase of 189,909 BBTX shares, $2.70M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Bambusa Therapeutics, Inc. (BBTX) | Purchase | 189,909 | $2.70M |
| Nov 2, 2026 | LENZ Therapeutics, Inc. (LENZ) | Sale | 2,159,516 | $7.26M |
| Oct 8, 2026 | Wave Life Sciences, Inc. (WVE) | Grant/Award | 10,700 | n/a |
| Oct 5, 2026 | Vor Biopharma Inc. (VOR) | Exercise/Conversion | 500 | $6.4K |
| Sep 30, 2026 | Climb Bio, Inc. (CLYM) | Exercise/Conversion | 10,000 | $34.6K |
| Sep 21, 2026 | Sionna Therapeutics, Inc. (SION) | Sale | 3,415,011 | $21.58M |
| Sep 17, 2026 | Tyra Biosciences, Inc. (TYRA) | Purchase | 9,078,529 | $199.99M |
| Sep 14, 2026 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/Award | 16,250 | n/a |
| Sep 8, 2026 | Artiva Biotherapeutics, Inc. (ARTV) | Grant/Award | 13,750 | n/a |
| Aug 26, 2026 | Vor Biopharma Inc. (VOR) | Exercise/Conversion | 1,500 | $5.6K |